We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
DMNB Adopts DNASTAR Lasergene Software
News

DMNB Adopts DNASTAR Lasergene Software

DMNB Adopts DNASTAR Lasergene Software
News

DMNB Adopts DNASTAR Lasergene Software

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "DMNB Adopts DNASTAR Lasergene Software"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

DNASTAR has announced that Dalhousie Medicine New Brunswick (DMNB) has entered into an agreement supporting an enterprise-wide site license of DNASTAR Lasergene software for genome sequence assembly and analysis.

The license provides access to the DNASTAR software for all faculty, staff and students of DMNB.

Dr. Keith Brunt, assistant professor at Dalhousie Medicine New Brunswick said, “Until we entered into this agreement, we didn’t have much experience with DNASTAR or their Lasergene software. The more time we spent using the software and the more we learned about its capabilities, the more impressed we were with it. By signing this agreement, we provide access to outstanding software for all of our scientists, faculty, staff and students at a very reasonable cost. This software will help in the training of a new generation of physicians and is a step toward patient tailored therapy. This agreement will help support the future success and growth of our program.”

Tom Schwei, Vice President and General Manager of DNASTAR, stated, “We are pleased to have entered into this agreement with Dalhousie Medicine New Brunswick. Our company was founded from an academic research environment and we continue to focus on ensuring we are serving the academic market well. We are particularly pleased to have DMNB as a customer, as their focus on medicine correlates well with a growing area of focus for our future software development. We appreciate the trust placed in our tools and company by DMNB’s management and we look forward to continuing to meet the organization’s sequence assembly and analysis software needs in the future.”

Financial terms of the arrangement were not disclosed.

Advertisement